comparemela.com
14
15
16
17
18
19
20
Latest Breaking News On - Gregory renza - Page 13 : comparemela.com
Aptose to Participate in RBC Capital Markets 2023 Global
SAN DIEGO and TORONTO, May 04, 2023 (GLOBE NEWSWIRE) Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage precision oncology company.
Toronto
Ontario
Canada
Susan-pietropaolo
William-rice
Gregory-renza
Aptose-biosciences
Nasdaq
Lifesci-advisors
Aptose-biosciences-inc
Equity-research-analyst
Chief-executive-officer
IDEAYA Biosciences to Participate in Upcoming May 2023 Investor Relations Event
/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted.
Gregory-renza
Yujiros-hata
Peter-lawson
Senior-biotechnology-research-analyst
Biosciences-inc
Exchange-commission
Nasdaq
Equity-research-analyst
Markets-global-healthcare
Chief-executive-officer
Senior-biotechnology-research
Managing-director
Wednesday's analyst upgrades and downgrades - The Globe and Mail
Inside the Market’s roundup of some of today’s key analyst actions
Burlington
Newfoundland
Canada
Montreal
Quebec
United-kingdom
Toronto
Ontario
China
United-states
Brookfield
Nova-scotia
RBC Capital Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
RBC Capital analyst Gregory Renza maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) on April 6 and set a price targ.
Dublin
Ireland
Brucec-cozadd
Larkin-finbar
Gregory-renza
Research-report-on
Jazz-pharmaceuticals
Jazz-pharmaceuticals-plc
Research-report
Moderate-buy
Pharmaceuticals-plc
Pfizer purchasing cancer-drug firm
Pfizer is purchasing cancer-drug maker Seagen for $43 billion, including company debt, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pharma.
France
French
Dinesh-nair
Gregory-renza
Clay-siegall
Albert-bourla
Provention-bio
Silicon-valley-bank
Pfizer
Bloomberg
Bloomberg-television-david-westin
Big-pharma
vimarsana © 2020. All Rights Reserved.